References
- Stupp R, Mason W P, van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–96
- Hegi M E, Diserens A C, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997–1003
- Taphoorn M JB, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 2005; 6: 937–44
- Jalali R, Singh P, Menon H, Gujral S. Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with temozolomide. J Neurooncol 2007, (epub ahead of print)
- Simpson J R, Hortan J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients of glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993; 26: 239–44
- Chamberlain M C, Glantz M J, Chalmers L, Van Horn A, Sloan A E. Early necrosis following concomitant temodar and radiotherapy in patients with glioblastoma. J Neurooncol 2007; 82: 81–83
- Leimgruber A, Ostermann S, Yeon E J, et al. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective TMZ clinical trial. Int J Radiat Oncol Bio Phys 2006; 64: 869–75